Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 545 entries
Sorted by: Best Match Show Resources per page
Allergic bronchopulmonary aspergillosis presenting with a pulmonary mass mimicking lung cancer.

Respirology case reports

Takeuchi Y, Shirai T, Sakurai S, Mikamo M, Fujii M, Suda T.
PMID: 25473526
Respirol Case Rep. 2013 Sep;1(1):5-7. doi: 10.1002/rcr2.4.

A 48-year-old man with a history of asthma visited our hospital for the investigation of a high density mass at the right hilum. Laboratory data revealed elevated serum carcinoembryonic antigen. A bronchoscopy was performed to rule out lung cancer;...

Cite
Takeuchi Y, Shirai T, Sakurai S, et al. Allergic bronchopulmonary aspergillosis presenting with a pulmonary mass mimicking lung cancer. Respirol Case Rep. 2013;1(1):5-7doi: 10.1002/rcr2.4.
Takeuchi, Y., Shirai, T., Sakurai, S., Mikamo, M., Fujii, M., & Suda, T. (2013). Allergic bronchopulmonary aspergillosis presenting with a pulmonary mass mimicking lung cancer. Respirology case reports, 1(1), 5-7. https://doi.org/10.1002/rcr2.4
Takeuchi, Yohei, et al. "Allergic bronchopulmonary aspergillosis presenting with a pulmonary mass mimicking lung cancer." Respirology case reports vol. 1,1 (2013): 5-7. doi: https://doi.org/10.1002/rcr2.4
Takeuchi Y, Shirai T, Sakurai S, Mikamo M, Fujii M, Suda T. Allergic bronchopulmonary aspergillosis presenting with a pulmonary mass mimicking lung cancer. Respirol Case Rep. 2013 Sep;1(1):5-7. doi: 10.1002/rcr2.4. PMID: 25473526; PMCID: PMC4184636.
Copy Download .nbib Format: NLM
Pulmonary cryptococcosis presenting with a large cavity.

Respirology case reports

Morita S, Shirai T, Asada K, Fujii M, Suzuki M, Suda T.
PMID: 25473568
Respirol Case Rep. 2014 Jun;2(2):61-3. doi: 10.1002/rcr2.49. Epub 2014 Feb 25.

A 78-year-old woman who was receiving corticosteroids for rheumatoid arthritis was admitted to our hospital to have her fever, hemoptysis, diarrhea, and chest x-ray abnormalities, which were unresponsive to antibiotics, investigated. A chest computed tomography scan revealed infiltrative shadows...

Cite
Morita S, Shirai T, Asada K, et al. Pulmonary cryptococcosis presenting with a large cavity. Respirol Case Rep. 2014;2(2):61-3doi: 10.1002/rcr2.49.
Morita, S., Shirai, T., Asada, K., Fujii, M., Suzuki, M., & Suda, T. (2014). Pulmonary cryptococcosis presenting with a large cavity. Respirology case reports, 2(2), 61-3. https://doi.org/10.1002/rcr2.49
Morita, Satoru, et al. "Pulmonary cryptococcosis presenting with a large cavity." Respirology case reports vol. 2,2 (2014): 61-3. doi: https://doi.org/10.1002/rcr2.49
Morita S, Shirai T, Asada K, Fujii M, Suzuki M, Suda T. Pulmonary cryptococcosis presenting with a large cavity. Respirol Case Rep. 2014 Jun;2(2):61-3. doi: 10.1002/rcr2.49. Epub 2014 Feb 25. PMID: 25473568; PMCID: PMC4184507.
Copy Download .nbib Format: NLM
Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.

Oncotarget

Montalban-Bravo G, Takahashi K, Patel K, Wang F, Xingzhi S, Nogueras GM, Huang X, Pierola AA, Jabbour E, Colla S, Gañan-Gomez I, Borthakur G, Daver N, Estrov Z, Kadia T, Pemmaraju N, Ravandi F, Bueso-Ramos C, Chamseddine A, Konopleva M, Zhang J, Kantarjian H, Futreal A, Garcia-Manero G.
PMID: 29515765
Oncotarget. 2018 Jan 03;9(11):9714-9727. doi: 10.18632/oncotarget.23882. eCollection 2018 Feb 09.

The prognostic and predictive value of sequencing analysis in myelodysplastic syndromes (MDS) has not been fully integrated into clinical practice. We performed whole exome sequencing (WES) of bone marrow samples from 83 patients with MDS and 31 with MDS/MPN...

Cite
Montalban-Bravo G, Takahashi K, Patel K, et al. Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms. Oncotarget. 2018;9(11):9714-9727doi: 10.18632/oncotarget.23882.
Montalban-Bravo, G., Takahashi, K., Patel, K., Wang, F., Xingzhi, S., Nogueras, G. M., Huang, X., Pierola, A. A., Jabbour, E., Colla, S., Gañan-Gomez, I., Borthakur, G., Daver, N., Estrov, Z., Kadia, T., Pemmaraju, N., Ravandi, F., Bueso-Ramos, C., Chamseddine, A., Konopleva, M., Zhang, J., Kantarjian, H., Futreal, A., & Garcia-Manero, G. (2018). Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms. Oncotarget, 9(11), 9714-9727. https://doi.org/10.18632/oncotarget.23882
Montalban-Bravo, Guillermo, et al. "Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms." Oncotarget vol. 9,11 (2018): 9714-9727. doi: https://doi.org/10.18632/oncotarget.23882
Montalban-Bravo G, Takahashi K, Patel K, Wang F, Xingzhi S, Nogueras GM, Huang X, Pierola AA, Jabbour E, Colla S, Gañan-Gomez I, Borthakur G, Daver N, Estrov Z, Kadia T, Pemmaraju N, Ravandi F, Bueso-Ramos C, Chamseddine A, Konopleva M, Zhang J, Kantarjian H, Futreal A, Garcia-Manero G. Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms. Oncotarget. 2018 Jan 03;9(11):9714-9727. doi: 10.18632/oncotarget.23882. eCollection 2018 Feb 09. PMID: 29515765; PMCID: PMC5839396.
Copy Download .nbib Format: NLM
The Toxicity and Benefit of Various Dosing Strategies for Interleukin-2 in Metastatic Melanoma and Renal Cell Carcinoma.

Journal of the advanced practitioner in oncology

Pachella LA, Madsen LT, Dains JE.
PMID: 26557408
J Adv Pract Oncol. 2015 May-Jun;6(3):212-21. Epub 2015 May 01.

Interleukin-2 (IL-2) therapy has been used with success in curing meta-static renal cell carcinoma and melanoma in a small minority of patients. However, the benefits can be accompanied by severe toxicity. This review of the literature discusses varying doses...

Cite
Pachella LA, Madsen LT, Dains JE. The Toxicity and Benefit of Various Dosing Strategies for Interleukin-2 in Metastatic Melanoma and Renal Cell Carcinoma. J Adv Pract Oncol. 2015;6(3):212-21
Pachella, L. A., Madsen, L. T., & Dains, J. E. (2015). The Toxicity and Benefit of Various Dosing Strategies for Interleukin-2 in Metastatic Melanoma and Renal Cell Carcinoma. Journal of the advanced practitioner in oncology, 6(3), 212-21.
Pachella, Laura A, et al. "The Toxicity and Benefit of Various Dosing Strategies for Interleukin-2 in Metastatic Melanoma and Renal Cell Carcinoma." Journal of the advanced practitioner in oncology vol. 6,3 (2015): 212-21.
Pachella LA, Madsen LT, Dains JE. The Toxicity and Benefit of Various Dosing Strategies for Interleukin-2 in Metastatic Melanoma and Renal Cell Carcinoma. J Adv Pract Oncol. 2015 May-Jun;6(3):212-21. Epub 2015 May 01. PMID: 26557408; PMCID: PMC4625627.
Copy Download .nbib Format: NLM
Hormone Replacement Therapy: An Increased Risk of Recurrence and Mortality for Breast Cancer Patients?.

Journal of the advanced practitioner in oncology

Lupo M, Dains JE, Madsen LT.
PMID: 26705493
J Adv Pract Oncol. 2015 Jul-Aug;6(4):322-30. doi: 10.6004/jadpro.2015.6.4.3. Epub 2015 Jul 01.

Historically, randomized controlled trials (RCTs) have shown an increased risk of recurrence and mortality among women who have used primarily oral HRT after breast cancer. However, many of these studies have had design flaws that may impact the findings....

Cite
Lupo M, Dains JE, Madsen LT. Hormone Replacement Therapy: An Increased Risk of Recurrence and Mortality for Breast Cancer Patients?. J Adv Pract Oncol. 2015;6(4):322-30doi: 10.6004/jadpro.2015.6.4.3.
Lupo, M., Dains, J. E., & Madsen, L. T. (2015). Hormone Replacement Therapy: An Increased Risk of Recurrence and Mortality for Breast Cancer Patients?. Journal of the advanced practitioner in oncology, 6(4), 322-30. https://doi.org/10.6004/jadpro.2015.6.4.3
Lupo, Molly, et al. "Hormone Replacement Therapy: An Increased Risk of Recurrence and Mortality for Breast Cancer Patients?." Journal of the advanced practitioner in oncology vol. 6,4 (2015): 322-30. doi: https://doi.org/10.6004/jadpro.2015.6.4.3
Lupo M, Dains JE, Madsen LT. Hormone Replacement Therapy: An Increased Risk of Recurrence and Mortality for Breast Cancer Patients?. J Adv Pract Oncol. 2015 Jul-Aug;6(4):322-30. doi: 10.6004/jadpro.2015.6.4.3. Epub 2015 Jul 01. PMID: 26705493; PMCID: PMC4677805.
Copy Download .nbib Format: NLM
A case of treatment with voriconazole for chronic progressive pulmonary aspergillosis in a patient receiving tacrolimus for dermatomyositis-associated interstitial lung disease.

Respiratory medicine case reports

Mochizuki E, Furuhashi K, Fujisawa T, Enomoto N, Inui N, Nakamura Y, Kono M, Hamada E, Maekawa M, Suda T.
PMID: 26744690
Respir Med Case Rep. 2015 Nov 03;16:163-5. doi: 10.1016/j.rmcr.2015.10.008. eCollection 2015.

We report a successful treatment with voriconazole (VRCZ) for chronic progressive pulmonary aspergillosis (CPPA) in a patient with dermatomyositis-associated interstitial lung disease (DM-ILD) treated with tacrolimus. A 73-year-old man with DM-ILD, treated with tacrolimus and prednisolone, complained of productive...

Cite
Mochizuki E, Furuhashi K, Fujisawa T, et al. A case of treatment with voriconazole for chronic progressive pulmonary aspergillosis in a patient receiving tacrolimus for dermatomyositis-associated interstitial lung disease. Respir Med Case Rep. 2015;16:163-5doi: 10.1016/j.rmcr.2015.10.008.
Mochizuki, E., Furuhashi, K., Fujisawa, T., Enomoto, N., Inui, N., Nakamura, Y., Kono, M., Hamada, E., Maekawa, M., & Suda, T. (2015). A case of treatment with voriconazole for chronic progressive pulmonary aspergillosis in a patient receiving tacrolimus for dermatomyositis-associated interstitial lung disease. Respiratory medicine case reports, 16163-5. https://doi.org/10.1016/j.rmcr.2015.10.008
Mochizuki, Eisuke, et al. "A case of treatment with voriconazole for chronic progressive pulmonary aspergillosis in a patient receiving tacrolimus for dermatomyositis-associated interstitial lung disease." Respiratory medicine case reports vol. 16 (2015): 163-5. doi: https://doi.org/10.1016/j.rmcr.2015.10.008
Mochizuki E, Furuhashi K, Fujisawa T, Enomoto N, Inui N, Nakamura Y, Kono M, Hamada E, Maekawa M, Suda T. A case of treatment with voriconazole for chronic progressive pulmonary aspergillosis in a patient receiving tacrolimus for dermatomyositis-associated interstitial lung disease. Respir Med Case Rep. 2015 Nov 03;16:163-5. doi: 10.1016/j.rmcr.2015.10.008. eCollection 2015. PMID: 26744690; PMCID: PMC4681998.
Copy Download .nbib Format: NLM
Alpha-fetoprotein-producing adenocarcinoma in which the metastatic route was determined from calcified lesions.

Clinical journal of gastroenterology

Tsuchiya A, Kanefuji T, Suda T, Aoyagi T, Osaki A, Togashi T, Kawauchi Y, Fushiki M, Watanabe G, Hirota M, Nomoto M, Ajioka Y, Aoyagi Y.
PMID: 26190712
Clin J Gastroenterol. 2011 Apr;4(2):89-94. doi: 10.1007/s12328-011-0209-x. Epub 2011 Feb 25.

Alpha-fetoprotein (AFP)-producing adenocarcinoma is known for its rapid progression and poor prognosis, and chemotherapy regimens are yet to be standardized. Here we describe the first report of AFP-producing adenocarcinoma with calcification. The metastatic route was visualized from the calcification,...

Cite
Tsuchiya A, Kanefuji T, Suda T, et al. Alpha-fetoprotein-producing adenocarcinoma in which the metastatic route was determined from calcified lesions. Clin J Gastroenterol. 2011;4(2):89-94doi: 10.1007/s12328-011-0209-x.
Tsuchiya, A., Kanefuji, T., Suda, T., Aoyagi, T., Osaki, A., Togashi, T., Kawauchi, Y., Fushiki, M., Watanabe, G., Hirota, M., Nomoto, M., Ajioka, Y., & Aoyagi, Y. (2011). Alpha-fetoprotein-producing adenocarcinoma in which the metastatic route was determined from calcified lesions. Clinical journal of gastroenterology, 4(2), 89-94. https://doi.org/10.1007/s12328-011-0209-x
Tsuchiya, Atsunori, et al. "Alpha-fetoprotein-producing adenocarcinoma in which the metastatic route was determined from calcified lesions." Clinical journal of gastroenterology vol. 4,2 (2011): 89-94. doi: https://doi.org/10.1007/s12328-011-0209-x
Tsuchiya A, Kanefuji T, Suda T, Aoyagi T, Osaki A, Togashi T, Kawauchi Y, Fushiki M, Watanabe G, Hirota M, Nomoto M, Ajioka Y, Aoyagi Y. Alpha-fetoprotein-producing adenocarcinoma in which the metastatic route was determined from calcified lesions. Clin J Gastroenterol. 2011 Apr;4(2):89-94. doi: 10.1007/s12328-011-0209-x. Epub 2011 Feb 25. PMID: 26190712.
Copy Download .nbib Format: NLM
Successful crizotinib monotherapy in .

Respiratory medicine case reports

Yoshimura K, Inui N, Karayama M, Inoue Y, Enomoto N, Fujisawa T, Nakamura Y, Takeuchi K, Sugimura H, Suda T.
PMID: 28271038
Respir Med Case Rep. 2017 Feb 17;20:160-163. doi: 10.1016/j.rmcr.2017.02.009. eCollection 2017.

No abstract available.

Cite
Yoshimura K, Inui N, Karayama M, et al. Successful crizotinib monotherapy in . Respir Med Case Rep. 2017;20:160-163doi: 10.1016/j.rmcr.2017.02.009.
Yoshimura, K., Inui, N., Karayama, M., Inoue, Y., Enomoto, N., Fujisawa, T., Nakamura, Y., Takeuchi, K., Sugimura, H., & Suda, T. (2017). Successful crizotinib monotherapy in . Respiratory medicine case reports, 20160-163. https://doi.org/10.1016/j.rmcr.2017.02.009
Yoshimura, Katsuhiro, et al. "Successful crizotinib monotherapy in ." Respiratory medicine case reports vol. 20 (2017): 160-163. doi: https://doi.org/10.1016/j.rmcr.2017.02.009
Yoshimura K, Inui N, Karayama M, Inoue Y, Enomoto N, Fujisawa T, Nakamura Y, Takeuchi K, Sugimura H, Suda T. Successful crizotinib monotherapy in . Respir Med Case Rep. 2017 Feb 17;20:160-163. doi: 10.1016/j.rmcr.2017.02.009. eCollection 2017. PMID: 28271038; PMCID: PMC5322209.
Copy Download .nbib Format: NLM
Formulation for Effective Screening and Management of Nonalcoholic Steatohepatitis: Noninvasive NAFLD Management Strategy.

Gastroenterology research and practice

Hirose K, Kanefuji T, Suda T, Sugitani S, Nagasaki K, Kubota T, Igarashi M, Terai S.
PMID: 27382367
Gastroenterol Res Pract. 2016;2016:6343656. doi: 10.1155/2016/6343656. Epub 2016 Jun 13.

To establish a versatile means for screening and management of nonalcoholic steatohepatitis (NASH), shear wave velocity was measured in 20 normal controls and 138 consecutive nonalcoholic fatty liver disease (NAFLD) cases. Referencing biochemical properties in 679 healthy volunteers, a...

Cite
Hirose K, Kanefuji T, Suda T, et al. Formulation for Effective Screening and Management of Nonalcoholic Steatohepatitis: Noninvasive NAFLD Management Strategy. Gastroenterol Res Pract. 2016;2016:6343656doi: 10.1155/2016/6343656.
Hirose, K., Kanefuji, T., Suda, T., Sugitani, S., Nagasaki, K., Kubota, T., Igarashi, M., & Terai, S. (2016). Formulation for Effective Screening and Management of Nonalcoholic Steatohepatitis: Noninvasive NAFLD Management Strategy. Gastroenterology research and practice, 20166343656. https://doi.org/10.1155/2016/6343656
Hirose, Kanae, et al. "Formulation for Effective Screening and Management of Nonalcoholic Steatohepatitis: Noninvasive NAFLD Management Strategy." Gastroenterology research and practice vol. 2016 (2016): 6343656. doi: https://doi.org/10.1155/2016/6343656
Hirose K, Kanefuji T, Suda T, Sugitani S, Nagasaki K, Kubota T, Igarashi M, Terai S. Formulation for Effective Screening and Management of Nonalcoholic Steatohepatitis: Noninvasive NAFLD Management Strategy. Gastroenterol Res Pract. 2016;2016:6343656. doi: 10.1155/2016/6343656. Epub 2016 Jun 13. PMID: 27382367; PMCID: PMC4921726.
Copy Download .nbib Format: NLM
Polarity-Specific Cortical Effects of Transcranial Direct Current Stimulation in Primary Somatosensory Cortex of Healthy Humans.

Frontiers in human neuroscience

Rehmann R, Sczesny-Kaiser M, Lenz M, Gucia T, Schliesing A, Schwenkreis P, Tegenthoff M, Höffken O.
PMID: 27242473
Front Hum Neurosci. 2016 May 09;10:208. doi: 10.3389/fnhum.2016.00208. eCollection 2016.

Transcranial direct current stimulation (tDCS) is a non-invasive stimulation method that has been shown to modulate the excitability of the motor and visual cortices in human subjects in a polarity dependent manner in previous studies. The aim of our...

Cite
Rehmann R, Sczesny-Kaiser M, Lenz M, et al. Polarity-Specific Cortical Effects of Transcranial Direct Current Stimulation in Primary Somatosensory Cortex of Healthy Humans. Front Hum Neurosci. 2016;10:208doi: 10.3389/fnhum.2016.00208.
Rehmann, R., Sczesny-Kaiser, M., Lenz, M., Gucia, T., Schliesing, A., Schwenkreis, P., Tegenthoff, M., & Höffken, O. (2016). Polarity-Specific Cortical Effects of Transcranial Direct Current Stimulation in Primary Somatosensory Cortex of Healthy Humans. Frontiers in human neuroscience, 10208. https://doi.org/10.3389/fnhum.2016.00208
Rehmann, Robert, et al. "Polarity-Specific Cortical Effects of Transcranial Direct Current Stimulation in Primary Somatosensory Cortex of Healthy Humans." Frontiers in human neuroscience vol. 10 (2016): 208. doi: https://doi.org/10.3389/fnhum.2016.00208
Rehmann R, Sczesny-Kaiser M, Lenz M, Gucia T, Schliesing A, Schwenkreis P, Tegenthoff M, Höffken O. Polarity-Specific Cortical Effects of Transcranial Direct Current Stimulation in Primary Somatosensory Cortex of Healthy Humans. Front Hum Neurosci. 2016 May 09;10:208. doi: 10.3389/fnhum.2016.00208. eCollection 2016. PMID: 27242473; PMCID: PMC4860403.
Copy Download .nbib Format: NLM
Ultrasound transmission tomography image distortions caused by the refraction effect.

Ultrasonics

Opielinski KJ, Gudra T.
PMID: 10829700
Ultrasonics. 2000 Mar;38(1):424-9. doi: 10.1016/s0041-624x(99)00137-7.

This paper presents the influence of ultrasonic beam ray refraction effect on the internal object structure imaging using the ultrasound transmission tomography method (UTT), in parallel ray projection geometry, for ultrasonic pulse run-time measurements. Simulation calculations carried out using...

Cite
Opielinski KJ, Gudra T. Ultrasound transmission tomography image distortions caused by the refraction effect. Ultrasonics. 2000;38(1):424-9doi: 10.1016/s0041-624x(99)00137-7.
Opielinski, K. J., & Gudra, T. (2000). Ultrasound transmission tomography image distortions caused by the refraction effect. Ultrasonics, 38(1), 424-9. https://doi.org/10.1016/s0041-624x(99)00137-7
Opielinski, and Gudra. "Ultrasound transmission tomography image distortions caused by the refraction effect." Ultrasonics vol. 38,1 (2000): 424-9. doi: https://doi.org/10.1016/s0041-624x(99)00137-7
Opielinski KJ, Gudra T. Ultrasound transmission tomography image distortions caused by the refraction effect. Ultrasonics. 2000 Mar;38(1):424-9. doi: 10.1016/s0041-624x(99)00137-7. PMID: 10829700.
Copy Download .nbib Format: NLM
Effects of random and systematic variations in unresolved cloud on recorded radiance and on target discriminability.

Applied optics

Duggin MJ, Schoch L, Cunia T, Piwinski D.
PMID: 18204572
Appl Opt. 1984 Feb 01;23(3):387. doi: 10.1364/ao.23.000387.

No abstract available.

Cite
Duggin MJ, Schoch L, Cunia T, et al. Effects of random and systematic variations in unresolved cloud on recorded radiance and on target discriminability. Appl Opt. 1984;23(3):387doi: 10.1364/ao.23.000387.
Duggin, M. J., Schoch, L., Cunia, T., & Piwinski, D. (1984). Effects of random and systematic variations in unresolved cloud on recorded radiance and on target discriminability. Applied optics, 23(3), 387. https://doi.org/10.1364/ao.23.000387
Duggin, M J, et al. "Effects of random and systematic variations in unresolved cloud on recorded radiance and on target discriminability." Applied optics vol. 23,3 (1984): 387. doi: https://doi.org/10.1364/ao.23.000387
Duggin MJ, Schoch L, Cunia T, Piwinski D. Effects of random and systematic variations in unresolved cloud on recorded radiance and on target discriminability. Appl Opt. 1984 Feb 01;23(3):387. doi: 10.1364/ao.23.000387. PMID: 18204572.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 545 entries